Anti‐COVID‐19 measurements for hidradenitis suppurativa patients

The reported incidence of COVID‐19 among cohorts of patients with inflammatory bowel and skin diseases under treatment with biologicals is low. Treatment may further modify disease severity as some biological modifiers, such as anakinra, are also proposed for the management of COVID‐19 patients pote...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Exp Dermatol
Hauptverfasser: Giamarellos‐Bourboulis, Evangelos J., Bettoli, Vincenzo, Jemec, Gregor B. E., del Marmol, Veronique, Marzano, Angelo V., Prens, Errol P., Tzellos, Thrasyvoulos, Zouboulis, Christos C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2021
Schlagworte:
10th European Hidradenitis Suppurativa (EHSF) e.V. Conference
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207032/
https://ncbi.nlm.nih.gov/pubmed/34085330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/exd.14339
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge